Toxicity assessment of nanosilver wound dressing in wistar rat

Acta Medica Iranica

Volumn 51, Issue 4, 2013, Pages 203-208

  Arbabi Bidgoli, Sepideh ^a   Mahdavi, Moujan ^a   Rezayat, Seyed Mahdi ^a,b   Korani, Mitra ^b   Amani, Amir ^b   Ziarati, Parisa ^a  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Nanosilver; Safety; Silver nitrate; Toxicity; Wound dressing

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANTIINFECTIVE AGENT; ASPARTATE AMINOTRANSFERASE; CALCIUM; CHOLESTEROL; CREATININE; NANOSILVER; SILVER; SILVER NANOPARTICLE; SILVER NITRATE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UREA; NANOPARTICLE; TOPICAL ANTIINFECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; ATOMIC FORCE MICROSCOPY; AUTOPSY; CONTROLLED STUDY; DRUG EFFICACY; DRUG RELEASE; DRUG SAFETY; ERYTHROCYTE COUNT; GROWTH RATE; HEMATOCRIT; HEMATOLOGICAL PARAMETERS; HISTOPATHOLOGY; KIDNEY MASS; LEUKOCYTE COUNT; LIVER TOXICITY; LIVER VEIN; LIVER WEIGHT; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; RAT; SCANNING ELECTRON MICROSCOPY; SKIN TOXICITY; TOXICITY TESTING; WOUND DRESSING; WOUND HEALING; ANIMAL; BANDAGE; BURN; DISEASE MODEL; METABOLISM; PATHOLOGY; PHYSIOLOGY; WISTAR RAT;

ANIMALS; ANTI-INFECTIVE AGENTS, LOCAL; BANDAGES; BURNS; DISEASE MODELS, ANIMAL; MALE; NANOPARTICLES; RATS; RATS, WISTAR; SILVER NITRATE; WOUND HEALING;

EID: 84886858838     PISSN: 00446025     EISSN: 17359694     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Costanza J, El Badawy AM, Tolaymat TM. Comment on "120 Years of Nanosilver History: Implications for Policy Makers". Environ Sci Technol 2011;45(17):7591-2.
2. Park SH, Im JH, Im JW, Chun BH, Kim JH. Adsorption Kinetics of Au and Ag Nanoparticles on Functionalized Glass Surfaces. Microchemical Journal 1999;63(1):71-91. http://www.sciencedirect.com/science/article/pii/S0026265 X99917691
3. Soni I, Salopek-Bondi B. Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. J. Colloid Interface Science 2004;275(1):1770-82.
4. Crosera M, Bovenzi M, Maina G, Adami G, Zanette C, Florio C, Filon Larese F. Nanoparticle dermal absorption and toxicity:: a review of the literature.: Int Arch Occup Environ Health 2009;82(9):1043-55.
5. Teodoro JS, Simões AM, Duarte FV, Rolo AP, Murdoch RC, Hussain SM, Palmeira CM. Assessment of the toxicity of silver nanoparticles in vitro: A mitochondrial perspective. Toxicol In Vitro 2011;25(3):664-705.
6. Monteiro DR, Gorup LF, Takamiya AS, Ruvollo-Filho AC, de Camargo ER, Barbosa DB. The growing importance of materials that prevent microbial adhesion: antimicrobial effect of medical devices containing silver. Int J Antimicrob Agents 2009;34(2):103-10.
7. M Korani, SM Rezayat, B Minaee, Arbabi Bidgoli S, Gilani K, Adeli S. Acute and subchronic dermal toxicity of nanosilver in guinea pig. Int J Nanomedicine 2011;6:855-62.
8. Poon VK, Burd A. In vitro cytotoxity of silver: implication for Clinical wound care. Burns 2004;30(2):140-7.
9. Paddle-Ledinek JE, Nasa Z, Cleland HJ. Effect of different Wound dressings on cell viability and proliferation. Plast Reconstr Surg 2006;117(7 Supple):110S-8S.
10. Cuttle L, Naidu S, Mill J, Hoskins W, Das K, Kimble RM. A retrospective cohort study of Acticoat versus Silvazine in a pediatric population. Burns 2007;33(6):701-7.
11. Benn T, Cavanagh B, Hristovski K, Posner JD, Westerhoff P. The release of nanosilver from consumer products used in the home. J Environ Qual 2010;39(6):1875-82.
12. National Research Council (US) Committee on Guidelines for the Use of Animals in Neuroscience and Behavioral Research. Guidelines for the Care and Use of Mammals in Neuroscience and Behavioral Research, Washington (DC): National Academies Press (US); 2003.
13. Fraser JF, Bodman J, Sturgess R, Faoagali J, Kimble RM. An inviro study of the anti-micribial efficacy of a 1% silver sulphadiazine and 0.2% chlorhexidine digluconate cream,1% silver sulphadiazine cream and a silver coated dressing. Burns 2004;30(1):35-41.
14. Siver S, Phung LeT, Silver G. Silver as biocides in burn and wound dressings and bacterial resistance to silver compounds. Microbial biotechnol 2006;33(7):627-34.
15. Geranio L, Heuberger M, Nowack B. The behavior of silver nanotextiles during washing. Environmental Science & Technology 2009;43(21):8113-8.
16. Stebounova LV, Adamcakova-Dodd A, Kim JS, Park H, O'Shaughnessy PT, Grassian VH, Thorne PS. Nanosilver induces minimal lung toxicity or inflammation in a subacute murine inhalation model. Part Fibre Toxicol 2011;8(1):5.
17. Hollinger MA. Toxicological aspects of topical silver pharmaceuticals. Crit Rev Toxicol 1996;26(3):255-60.
18. Tang J, Xi T. Status of biological evaluation on silver nanoparticles. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 2008;25(4):958-61.